Successful therapy confirmed for newborns with fatal metabolic disorder MoCD type A

The drug fosdenopterin/rcPMP considerably improves the chances of survival and developmental progress in infants with molybdenum cofactor deficiency (MoCD type A), a rare and life-threatening genetic condition causing an inborn error in metabolism. This was shown in a clinical study recently published by an international research team led by Professor Dr. Günter Schwarz from the Institute of Biochemistry at the University of Cologne.
Read More

More fruit and less processed meat: A recipe for fewer diseases in the Netherlands by 2050

The Netherlands could have approximately 20% fewer new cases of diabetes, coronary heart disease, and strokes by 2050, if all Dutch citizens were to consume two pieces of fruit daily and refrain from eating processed meat such as sausages and hamburgers. This is the conclusion of research conducted by Wageningen University & Research (WUR). The researchers published their findings in eClinicalMedicine.
Read More

New way to grow iPS cell-derived kidney progenitor cells may lead to renal regenerative therapies

Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective means to grow iPS cell-derived kidney progenitor cells, paving the way for renal regenerative therapies to become a reality. The findings are published in the journal Science Translational Medicine.
Read More

Novel probiotic strain proves more effective for treating a common intestinal infection

Giardiasis, caused by the protozoan Giardia intestinalis, is the leading cause of intestinal parasitic infections in humans and pets, in particular dogs. Some of the main symptoms are diarrhea, abdominal pain, nausea and weight loss. Additionally, it can lead to post-infectious complications such as irritable bowel syndrome (IBS) and chronic fatigue.
Read More
Top